How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

The Fay W. Whitney School of Nursing offers several ways to earn a Bachelor of Science in Nursing, depending on your previous education and experience. Explore our BSN options to find the program that ...

The Summer Undergraduate Research Program (SURP) is an intensive, nine-week internship for undergraduates entering the summer before their final year, semester, or quarter of study. It's designed to ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...